Literature DB >> 21879735

Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.

Alamelu Mahalingam1, Anthony R Geonnotti, Jan Balzarini, Patrick F Kiser.   

Abstract

Lectins derived from plant and microbial sources constitute a vital class of entry inhibitors that target the oligomannose residues on the HIV envelope gp120. Despite their potency and specificity, success of lectin-based entry inhibitors may be impeded by high manufacturing costs, formulation and potential mitogenicity. Therefore, there exists a gap in the HIV microbicides pipeline that underscores the need for mass producible, synthetic, broad-spectrum, and biocomptabile inhibitors of HIV entry. Here, we present the development of a polymeric synthetic lectin, based on benzoboroxole (BzB), which exhibits weak affinity (∼25 M(-1)) for nonreducing sugars, similar to those found on the HIV envelope. High molecular weight BzB-functionalized polymers demonstrated antiviral activity that increased with an increase in ligand density and molecular weight of the polymer construct, revealing that polyvalency improves activity. Polymers showed significant increase in activity from 25 to 75 mol % BzB functionalization with EC(50) of 15 μM and 15 nM, respectively. A further increase in mole functionalization to 90% resulted in an increase of the EC(50) (59 ± 5 nM). An increase in molecular weight of the polymer at 50 mol % BzB functionalization showed a gradual but significant increase in antiviral activity, with the highest activity seen with the 382 kDa polymer (EC(50) of 1.1 ± 0.5 nM in CEM cells and 11 ± 3 nM in TZM-bl cells). Supplementing the polymer backbone with 10 mol % sulfonic acid not only increased the aqueous solubility of the polymers by at least 50-fold but also demonstrated a synergistic increase in anti-HIV activity (4.0 ± 1.5 nM in TZM-bl cells), possibly due to electrostatic interactions between the negatively charged polymer backbone and the positively charged V3-loop in the gp120. The benzoboroxole-sulfonic acid copolymers showed no decrease in activity in the presence of a seminal concentration of fructose (p > 0.05). Additionally, the copolymers exhibit minimal, if any, effect on the cellular viability, barrier properties, or cytokine levels in human reconstructed ectocervical tissue after 3 days of repeated exposure and did not show pronounced activity against a variety of other RNA and DNA viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879735      PMCID: PMC3445258          DOI: 10.1021/mp2002957

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  46 in total

1.  Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.

Authors:  Jan Balzarini; Kristel Van Laethem; Sigrid Hatse; Matheus Froeyen; Els Van Damme; Anders Bolmstedt; Willy Peumans; Erik De Clercq; Dominique Schols
Journal:  Mol Pharmacol       Date:  2005-02-17       Impact factor: 4.436

2.  Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.

Authors:  François Helle; Czeslaw Wychowski; Ngoc Vu-Dac; Kirk R Gustafson; Cécile Voisset; Jean Dubuisson
Journal:  J Biol Chem       Date:  2006-06-29       Impact factor: 5.157

3.  Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.

Authors:  Jan Balzarini; Kristel Van Laethem; Dirk Daelemans; Sigrid Hatse; Antonella Bugatti; Marco Rusnati; Yasuhiro Igarashi; Toshikazu Oki; Dominique Schols
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

4.  Sterically blocking adhesion of cells to biological surfaces with a surface-active copolymer containing poly(ethylene glycol) and phenylboronic acid.

Authors:  Natalie D Winblade; Hugo Schmökel; Marion Baumann; Allan S Hoffman; Jeffrey A Hubbell
Journal:  J Biomed Mater Res       Date:  2002-03-15

5.  3-Methoxycarbonyl-5-nitrophenyl boronic acid: high affinity diol recognition at neutral pH.

Authors:  Hormuzd R Mulla; Nicholas J Agard; Amit Basu
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

6.  Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.

Authors:  Julie I Jay; Bonnie E Lai; David G Myszka; Alamelu Mahalingam; Kris Langheinrich; David F Katz; Patrick F Kiser
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

7.  PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

Authors:  Sheena McCormack; Gita Ramjee; Anatoli Kamali; Helen Rees; Angela M Crook; Mitzy Gafos; Ute Jentsch; Robert Pool; Maureen Chisembele; Saidi Kapiga; Richard Mutemwa; Andrew Vallely; Thesla Palanee; Yuki Sookrajh; Charles J Lacey; Janet Darbyshire; Heiner Grosskurth; Albert Profy; Andrew Nunn; Richard Hayes; Jonathan Weber
Journal:  Lancet       Date:  2010-09-17       Impact factor: 79.321

8.  Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.

Authors:  Viviana Buffa; Daniel Stieh; Naheed Mamhood; Qinxue Hu; Patricia Fletcher; Robin J Shattock
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

9.  Benzoboroxoles as efficient glycopyranoside-binding agents in physiological conditions: structure and selectivity of complex formation.

Authors:  Marie Bérubé; Meenakshi Dowlut; Dennis G Hall
Journal:  J Org Chem       Date:  2008-06-13       Impact factor: 4.354

Review 10.  Virus glycosylation: role in virulence and immune interactions.

Authors:  David J Vigerust; Virginia L Shepherd
Journal:  Trends Microbiol       Date:  2007-03-29       Impact factor: 17.079

View more
  12 in total

1.  A General Method for Selective Recognition of Monosaccharides and Oligosaccharides in Water.

Authors:  Roshan W Gunasekara; Yan Zhao
Journal:  J Am Chem Soc       Date:  2017-01-03       Impact factor: 15.419

2.  Intravaginal flux controlled pump for sustained release of macromolecules.

Authors:  Ryan S Teller; Rachna Rastogi; Todd J Johnson; Michael J Blair; Robert W Hitchcock; Patrick F Kiser
Journal:  Pharm Res       Date:  2014-05-02       Impact factor: 4.200

3.  Membrane adsorbers comprising grafted glycopolymers for targeted lectin binding.

Authors:  Heather C S Chenette; Scott M Husson
Journal:  J Appl Polym Sci       Date:  2015-06-05       Impact factor: 3.125

4.  Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.

Authors:  Tong-Cui Ma; Run-Hong Zhou; Xu Wang; Jin-Biao Liu; Jie-Liang Li; Yu Zhou; Wei Hou; Wen-Zhe Ho
Journal:  Virology       Date:  2017-10-16       Impact factor: 3.616

Review 5.  Long-acting slow effective release antiretroviral therapy.

Authors:  Benson Edagwa; JoEllyn McMillan; Brady Sillman; Howard E Gendelman
Journal:  Expert Opin Drug Deliv       Date:  2017-02-06       Impact factor: 6.648

6.  New conjugates of polyene macrolide amphotericin B with benzoxaboroles: synthesis and properties.

Authors:  Anna N Tevyashova; Alexander M Korolev; Aleksey S Trenin; Lyubov G Dezhenkova; Alexander A Shtil; Vladimir I Polshakov; Oleg Yu Savelyev; Evgenia N Olsufyeva
Journal:  J Antibiot (Tokyo)       Date:  2016-03-23       Impact factor: 2.649

7.  In Vitro Characterization of the Carbohydrate-Binding Agents HHA, GNA, and UDA as Inhibitors of Influenza A and B Virus Replication.

Authors:  Evelien Vanderlinden; Nathalie Van Winkel; Lieve Naesens; Els J M Van Damme; Leentje Persoons; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

Review 8.  Recent Progress in Lectin-Based Biosensors.

Authors:  Baozhen Wang; Jun-Ichi Anzai
Journal:  Materials (Basel)       Date:  2015-12-09       Impact factor: 3.623

9.  Fabrication of Cationic Poly(vinyl alcohol) Films Cross-Linked Using Copolymers Containing Quaternary Ammonium Cations, Benzoxaborole, and Carboxy Groups.

Authors:  Kazuma Fujimoto; Aika Yamawaki-Ogata; Yuji Narita; Yohei Kotsuchibashi
Journal:  ACS Omega       Date:  2021-06-29

10.  Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei.

Authors:  Pieter C Steketee; Isabel M Vincent; Fiona Achcar; Federica Giordani; Dong-Hyun Kim; Darren J Creek; Yvonne Freund; Robert Jacobs; Kevin Rattigan; David Horn; Mark C Field; Annette MacLeod; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.